Substituted cyclopentanes having prostaglanding activity

Details for Australian Patent Application No. 2008324793 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.; Nguyen, Jeremiah H.; Donde, Yariv

Agent Davies Collison Cave

Pub. Number AU-A-2008324793

PCT Pub. Number WO2009/061811

Priority 60/986,849 09.11.07 US; 12/265,062 05.11.08 US

Filing date 5 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 263/34 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 333/40 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/061811 Priority application(s): WO2009/061811

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324795-Multi-frequency neural treatments and associated systems and methods

2008324789-Activin receptor-like kinase-1 antagonist compositions and methods of use